| Ad Title: |
An Open-Label Extension Study of Rufinamide Given as Adjunctive Therapy in Patients with Refractory Partial Seizures |
| Study Title: |
E2080-A001-302: An Open Label-Extension Study of Rufinamide Given as Adjunctive Therapy in Patients with Refractory Partial Onset Seizures |
| Protocol Number: |
112007-013 |
| Department(s) involved in the Study: |
Neurology
|
| Purpose of the Study: |
Evaluate the safety and efficacy of long-term administration of Rufinamide in patients with Refractory Partial Onset Seizures. |
| Participant Eligibility: |
* Must have completed or be enrolled in the Double-Blind, Placebo-Controlled Rufinamide study.
* Patients from the age of 18-80. |
| Disease/Condition Under Study: |
Epilepsy-Refractory Partial Onset Seizures. |
| Cancer Related Study: |
No
|
| Study Drug(s): |
Rufinamide (Phase III)
|
| Study Device(s): |
|
| Study Doctor: |
Dr. Paul Van Ness |
| Location of Study: |
|
Sites
|
Recruiting at this Site
|
|
Aston Ambulatory Care Center
|
Yes
|
|
| Contact Phone: |
214_648_6721 |
| Email: |
paul.van_ness@utsouthwestern.edu |
| Other Information: |
|
| Website Keywords: |
Neurology
|
| Medical Keywords: |
Epilepsy
|
